<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33000451</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>01</Day></DateCompleted><DateRevised><Year>2021</Year><Month>09</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1559-1182</ISSN><JournalIssue CitedMedium="Internet"><Volume>58</Volume><Issue>2</Issue><PubDate><Year>2021</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Molecular neurobiology</Title><ISOAbbreviation>Mol Neurobiol</ISOAbbreviation></Journal><ArticleTitle>L-Citrulline Level and Transporter Activity Are Altered in Experimental Models of Amyotrophic Lateral Sclerosis.</ArticleTitle><Pagination><StartPage>647</StartPage><EndPage>657</EndPage><MedlinePgn>647-657</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s12035-020-02143-6</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a progressive motor neuron disease caused by the death of the neurons regulating the voluntary muscles which leads to the progressive paralysis. We investigated the difference of transport function of L-citrulline in ALS disease model (NSC-34/hSOD1<sup>G93A</sup>, MT) and a control model (NSC-34/hSOD1<sup>wt</sup>, WT). The [<sup>14</sup>C]L-citrulline uptake was significantly reduced in MT cells as compared with that of control. The Michaelis-Menten constant (K<sub>m</sub>) for MT cells was 0.67&#x2009;&#xb1;&#x2009;0.05&#xa0;mM, whereas it was 1.48&#x2009;&#xb1;&#x2009;0.21&#xa0;mM for control. On the other hand, the V<sub>max</sub> values for MT and control were 10.9&#x2009;&#xb1;&#x2009;0.8&#xa0;nmol/mg protein/min and 18.3&#x2009;&#xb1;&#x2009;2.9&#xa0;nmol/mg protein/min, respectively. The K<sub>m</sub> and V<sub>max</sub> values showed the high affinity and low capacity for MT as compared with control. Moreover, the uptake of [<sup>14</sup>C]L-citrulline was significantly inhibited by 2-aminobicyclo-(2,2,1)-heptane-2-carboxylic acid (BCH) and harmaline which is the inhibitor of the large neutral amino acid transporter1 (LAT1) in NSC-34 cell lines. Furthermore, [<sup>14</sup>C]L-citrulline uptakes took place in Na<sup>+</sup>-independent manner. It was also inhibited by the neutral amino acids such as citrulline and phenylalanine. Likewise, L-dopa, gabapentin, and riluzole significantly inhibited the [<sup>14</sup>C]L-citrulline uptake. It shows the competitive inhibition for L-dopa in ALS cell lines. On the other hand, [<sup>14</sup>C]L-citrulline uptake in the presence of riluzole showed competitive inhibition in WT cells, whereas it was uncompetitive for MT cells. The small interfering RNA experiments showed that LAT1 is involved in the [<sup>14</sup>C]L-citrulline uptake in NSC-34 cell lines. On the other hand, in the examination of the alteration in the expression level of LAT1, it was significantly lower in MT cells as compared with that of control. Similarly, in the spinal cord of ALS, transgenic mice revealed a slight but significant decrease in LAT1 immunoreactivity in motor neurons of ALS mice compared with control. However, the LAT1 immunoreactivity in non-motor neurons and in astrocytes was relatively increased in the spinal cord gray matter of ALS mice. The experimental evidences of our results suggest that the change of transport activity of [<sup>14</sup>C]L-citrulline may be partially responsible for the pathological alteration in ALS.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Gyawali</LastName><ForeName>Asmita</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>College of Pharmacy and Drug Information Research Institute, Sookmyung Women's University, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Gautam</LastName><ForeName>Shashi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>College of Pharmacy and Drug Information Research Institute, Sookmyung Women's University, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hyeon</LastName><ForeName>Seung Jae</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Laboratory for Brain Gene Regulation and Epigenetics, Center for Neuroscience, Korea Institute of Science and Technology, Seoul, 02792, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryu</LastName><ForeName>Hoon</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Laboratory for Brain Gene Regulation and Epigenetics, Center for Neuroscience, Korea Institute of Science and Technology, Seoul, 02792, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Boston University Alzheimer's Disease Center Department of Neurology, Boston University School of Medicine, Boston, MA, 02183, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kang</LastName><ForeName>Young-Sook</ForeName><Initials>YS</Initials><Identifier Source="ORCID">0000-0002-8573-4657</Identifier><AffiliationInfo><Affiliation>College of Pharmacy and Drug Information Research Institute, Sookmyung Women's University, Seoul, Republic of Korea. yskang@sm.ac.kr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2019R1F1A1044048</GrantID><Agency>National Research Foundation of Korea</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>10</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Mol Neurobiol</MedlineTA><NlmUniqueID>8900963</NlmUniqueID><ISSNLinking>0893-7648</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D027241">Amino Acid Transport System y+L</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002250">Carbon Radioisotopes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D027283">Large Neutral Amino Acid-Transporter 1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D026901">Membrane Transport Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D034741">RNA, Small Interfering</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000629866">Slc7a5 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C518287">Slc7a7 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>29VT07BGDA</RegistryNumber><NameOfSubstance UI="D002956">Citrulline</NameOfSubstance></Chemical><Chemical><RegistryNumber>7V68J5677O</RegistryNumber><NameOfSubstance UI="C000615234">Carbon-14</NameOfSubstance></Chemical><Chemical><RegistryNumber>9NEZ333N27</RegistryNumber><NameOfSubstance UI="D012964">Sodium</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D027241" MajorTopicYN="N">Amino Acid Transport System y+L</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001253" MajorTopicYN="N">Astrocytes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001692" MajorTopicYN="N">Biological Transport</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002250" MajorTopicYN="N">Carbon Radioisotopes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002956" MajorTopicYN="N">Citrulline</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007700" MajorTopicYN="N">Kinetics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D027283" MajorTopicYN="N">Large Neutral Amino Acid-Transporter 1</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D026901" MajorTopicYN="N">Membrane Transport Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D034741" MajorTopicYN="N">RNA, Small Interfering</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012964" MajorTopicYN="N">Sodium</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013116" MajorTopicYN="N">Spinal Cord</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015854" MajorTopicYN="N">Up-Regulation</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis (ALS)</Keyword><Keyword MajorTopicYN="N">Carrier mediated transporter</Keyword><Keyword MajorTopicYN="N">L-citrulline</Keyword><Keyword MajorTopicYN="N">LAT1 (large neutral amino acid transporter 1)</Keyword><Keyword MajorTopicYN="N">Motor neuron disease</Keyword><Keyword MajorTopicYN="N">NSC-34 cells</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>2</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>9</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>10</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>10</Month><Day>1</Day><Hour>5</Hour><Minute>41</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33000451</ArticleId><ArticleId IdType="doi">10.1007/s12035-020-02143-6</ArticleId><ArticleId IdType="pii">10.1007/s12035-020-02143-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Luiking YC, Engelen MP, Deutz NE (2010) Regulation of nitric oxide production in health and disease. Curr Opin Clin Nutr Metab Care 13(1):97&#x2013;104</Citation><ArticleIdList><ArticleId IdType="pubmed">19841582</ArticleId><ArticleId IdType="pmc">2953417</ArticleId></ArticleIdList></Reference><Reference><Citation>Rimando AM, Perkins-Veazie PM (2005) Determination of citrulline in watermelon rind. J Chromatogr A 1078(1&#x2013;2):196&#x2013;200</Citation><ArticleIdList><ArticleId IdType="pubmed">16007998</ArticleId></ArticleIdList></Reference><Reference><Citation>Olsen I, Singhrao SK, Potempa JJ (2018) Citrullination as a plausible link to periodontitis, rheumatoid arthritis, atherosclerosis and Alzheimer's disease. J Oral Microbiol 10(1):1487742</Citation><ArticleIdList><ArticleId IdType="pubmed">29963294</ArticleId><ArticleId IdType="pmc">6022223</ArticleId></ArticleIdList></Reference><Reference><Citation>Allerton TD, Proctor DN, Stephens JM, Dugas T, Spielmann G, Irving B (2018) L-Citrulline supplementation: impact on cardiometabolic health. Nutrients 10(7):921</Citation><ArticleIdList><ArticleId IdType="pmc">6073798</ArticleId></ArticleIdList></Reference><Reference><Citation>Bahri S, Zerrouk N, Aussel C, Moinard C, Crenn P, Curis E, Chaumeil JC, Cynober L et al (2013) Citrulline: from metabolism to therapeutic use. Nutrition 29(3):479&#x2013;484</Citation><ArticleIdList><ArticleId IdType="pubmed">23022123</ArticleId></ArticleIdList></Reference><Reference><Citation>Lameu C, Trujillo CA, Schwindt TT, Negraes PD, Pillat MM, Morais KL, Lebrun I, Ulrich H (2012) Interactions between the NO-citrulline cycle and brain-derived neurotrophic factor in differentiation of neural stem cells. J Biol Chem 287(35):29690&#x2013;29701</Citation><ArticleIdList><ArticleId IdType="pubmed">22730318</ArticleId><ArticleId IdType="pmc">3436173</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu C, Liang MC, Soong TW (2019) Nitric oxide, iron and neurodegeneration. Front Neurosci 13:114</Citation><ArticleIdList><ArticleId IdType="pubmed">30833886</ArticleId><ArticleId IdType="pmc">6388708</ArticleId></ArticleIdList></Reference><Reference><Citation>Moinard C, Maccario J, Walrand S, Lasserre V, Marc J, Boirie Y, Cynober L (2016) Arginine behaviour after arginine or citrulline administration in older subjects. Br J Nutr 115(3):399&#x2013;404</Citation><ArticleIdList><ArticleId IdType="pubmed">26619904</ArticleId></ArticleIdList></Reference><Reference><Citation>Gubert F, Bonacossa-Pereira I, Decotelli AB, Furtado M, Vasconcelos-dos-Santos A, Mendez-Otero R, Santiago MF (2019) Bone-marrow mononuclear cell therapy in a mouse model of amyotrophic lateral sclerosis: functional outcomes from different administration routes. Brain Res 1712:73&#x2013;81</Citation><ArticleIdList><ArticleId IdType="pubmed">30735638</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, Chi&#xf2; A, Traynor BJ (2014) State of play in amyotrophic lateral sclerosis genetics. Nat Neurosci 17(1):17&#x2013;23</Citation><ArticleIdList><ArticleId IdType="pubmed">24369373</ArticleId></ArticleIdList></Reference><Reference><Citation>Stuerenburg HJ, Stangneth B, Schoser BG (2006) Age related profiles of free amino acids in human skeletal muscle. Neuro Endocrinol Lett 27(1&#x2013;2):133&#x2013;136</Citation><ArticleIdList><ArticleId IdType="pubmed">16648814</ArticleId></ArticleIdList></Reference><Reference><Citation>Sau D, De Biasi S, Vitellaro-Zuccarello L et al (2007) Mutation of SOD1 in ALS: a gain of a loss of function. Hum Mol Genet 16(13):1604&#x2013;1618</Citation><ArticleIdList><ArticleId IdType="pubmed">17504823</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J, Ryu H, Kowall NW (2009) Motor neuronal protection by l-arginine prolongs survival of mutant SOD1 (G93A) ALS mice. Biochem Biophys Res Commun 384(4):524&#x2013;529</Citation><ArticleIdList><ArticleId IdType="pubmed">19427829</ArticleId><ArticleId IdType="pmc">2744197</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu D, Bao F, Wen J, Liu J (2007) Mutation of superoxide dismutase elevates reactive species: comparison of nitration and oxidation of proteins in different brain regions of transgenic mice with amyotrophic lateral sclerosis. Neuroscience 146(1):255&#x2013;264</Citation><ArticleIdList><ArticleId IdType="pubmed">17368952</ArticleId></ArticleIdList></Reference><Reference><Citation>Yabuki Y, Shioda N, Yamamoto Y, Shigano M, Kumagai K, Morita M, Fukunaga K (2013) Oral L-Citrulline administration improves memory deficits following transient brain ischemia through cerebrovascular protection. Brain Res 1520:157&#x2013;167</Citation><ArticleIdList><ArticleId IdType="pubmed">23685189</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee KE, Kang YS (2017) Characteristics of L-citrulline transport through blood-brain barrier in the brain capillary endothelial cell line (TR-BBB cells). J Biomed Sci 24:28</Citation><ArticleIdList><ArticleId IdType="pubmed">28490336</ArticleId><ArticleId IdType="pmc">5424428</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J, Ryu H, Kowall NW (2009) Differential regulation of neuronal and inducible nitric oxide synthase (NOS) in the spinal cord of mutant SOD1 (G93A) ALS mice. Biochem Biophys Res Commun 387(1):202&#x2013;206</Citation><ArticleIdList><ArticleId IdType="pubmed">19580782</ArticleId><ArticleId IdType="pmc">2742676</ArticleId></ArticleIdList></Reference><Reference><Citation>Gyawali A, Kang YS (2019) Blood-to-retina transport of imperatorin involves the carrier-mediated transporter system at the inner blood-retinal barrier. J Pharm Sci 108(4):1619&#x2013;1626</Citation><ArticleIdList><ArticleId IdType="pubmed">30528198</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee NY, Kim Y, Ryu H, Kang YS (2017) The alteration of serine transporter activity in a cell line model of amyotrophic lateral sclerosis (ALS). Biochem Biophys Res Commun 483(1):135&#x2013;141</Citation><ArticleIdList><ArticleId IdType="pubmed">28043791</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang YS, Ohtsuki S, Takanaga H, Tomi M, Hosoya KI, Terasaki T (2002) Regulation of taurine transport at the blood&#x2013;brain barrier by tumor necrosis factor-alpha, taurine and hypertonicity. J Neurochem 83(5):1188&#x2013;1195</Citation><ArticleIdList><ArticleId IdType="pubmed">12437590</ArticleId></ArticleIdList></Reference><Reference><Citation>Gyawali A, Krol S, Kang YS (2019) Involvement of a novel organic cation transporter in paeonol transport across the blood-brain barrier. Biomol Ther 27(3):290&#x2013;301</Citation></Reference><Reference><Citation>Lee NY, Kang YS (2016) In vivo and in vitro evidence for brain uptake of 4-phenylbutyrate by the monocarboxylate transporter 1 (MCT1). Pharm Res 33(7):1711&#x2013;1722</Citation><ArticleIdList><ArticleId IdType="pubmed">27026010</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryu H, Lee J, Hagerty SW, Soh BY, McAlpin SE, Cormier KA, Smith KM, Ferrante RJ (2006) ESET/SETDB1 gene expression and histone H3 (K9) trimethylation in Huntington&#x2019;s disease. Proc Natl Acad Sci U S A 103(50):19176&#x2013;19181</Citation><ArticleIdList><ArticleId IdType="pubmed">17142323</ArticleId><ArticleId IdType="pmc">1748195</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung MK, Kim KY, Lee NY, Kang YS, Hwang YJ, Kim Y, Sung JJ, McKee A et al (2013) Expression of taurine transporter (TauT) is modulated by heat shock factor 1 (HSF1) in motor neurons of ALS. Mol Neurobiol 47(2):699&#x2013;710</Citation><ArticleIdList><ArticleId IdType="pubmed">23180277</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasabe J, Chiba T, Yamada M, Okamoto K, Nishimoto I, Matsuoka M, Aiso S (2007) D-serine is a key determinant of glutamate toxicity in amyotrophic lateral sclerosis. EMBO J 26(18):4149&#x2013;4159</Citation><ArticleIdList><ArticleId IdType="pubmed">17762863</ArticleId><ArticleId IdType="pmc">2230675</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasabe J, Miyoshi Y, Suzuki M et al (2012) D-amino acid oxidase controls motoneuron degeneration through D serine. Proc Natl Acad Sci U S A 109(2):627&#x2013;632</Citation><ArticleIdList><ArticleId IdType="pubmed">22203986</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Kane RL, Vi&#xf1;a JR, Simpson I et al (2006) Cationic amino acid transport across the blood&#x2013;brain barrier is mediated exclusively by system y+. Am J Physiol Endocrinol Metab 291(2):412&#x2013;419</Citation></Reference><Reference><Citation>Zhan X, Graf WM (2012) Harmaline attenuates voltage--sensitive Ca (2+) currents in neurons of the inferior olive. J Pharm Sci 15(5):657&#x2013;668</Citation></Reference><Reference><Citation>Pingitore P, Pochini L, Scalise M, Galluccio M, Hedfalk K, Indiveri C (2013) Large scale production of the active human ASCT2 (SLC1A5) transporter in Pichia pastoris &#x2014; functional and kinetic asymmetry revealed in proteoliposomes. Biochim Biophys Acta 1828(9):2238&#x2013;2246</Citation><ArticleIdList><ArticleId IdType="pubmed">23756778</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukasawa Y, Segawa H, Kim JY, Chairoungdua A, Kim DK, Matsuo H, Cha SH, Endou H et al (2000) Identification and characterization of a Na(+)-independent neutral amino acid transporter that associates with the 4F2 heavy chain and exhibits substrate selectivity for small neutral D- and L-amino acids. J Biol Chem 275(13):9690&#x2013;9698</Citation><ArticleIdList><ArticleId IdType="pubmed">10734121</ArticleId></ArticleIdList></Reference><Reference><Citation>Dev&#xe9;s R, Boyd CA (1998) Transporters for cationic amino acids in animal cells: discovery, structure, and function. Physiol Rev 78(2):487&#x2013;545</Citation><ArticleIdList><ArticleId IdType="pubmed">9562037</ArticleId></ArticleIdList></Reference><Reference><Citation>Boado RJ, Li JY, Nagaya M et al (1999) Selective expression of the large neutral amino acid transporter at the blood&#x2013;brain barrier. Proc Natl Acad Sci U S A 96(21):12079&#x2013;12084</Citation><ArticleIdList><ArticleId IdType="pubmed">10518579</ArticleId><ArticleId IdType="pmc">18415</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsuo H, Tsukada S, Nakata T, Chairoungdua A, Kim DK, Cha SH, Inatomi J, Yorifuji H et al (2000) Expression of a system L neutral amino acid transporter at the blood&#x2013;brain barrier. Neuroreport 11(16):3507&#x2013;3511</Citation><ArticleIdList><ArticleId IdType="pubmed">11095508</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorheim MA, Tracey WR, Pollock JS, Grammas P (1994) Nitric oxide synthase activity is elevated in brain microvessels in Alzheimer&#x2019;s disease. Biochem Biophys Res Commun 205(1):659&#x2013;665</Citation><ArticleIdList><ArticleId IdType="pubmed">7528015</ArticleId></ArticleIdList></Reference><Reference><Citation>Skene DJ, Middleton B, Fraser CK, Pennings JL et al (2017) Metabolic profiling of presymptomatic Huntington&#x2019;s disease sheep reveals novel biomarkers. Sci Rep 7:43030</Citation><ArticleIdList><ArticleId IdType="pubmed">28223686</ArticleId><ArticleId IdType="pmc">5320451</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiang MC, Chen HM, Lee YH, Chang HH, Wu YC, Soong BW, Chen CM, Wu YR et al (2007) Dysregulation of C/EBP&#x3b1; by mutant Huntingtin causes the urea cycle deficiency in Huntington's disease. Hum Mol Genet 16:483&#x2013;498</Citation><ArticleIdList><ArticleId IdType="pubmed">17213233</ArticleId></ArticleIdList></Reference><Reference><Citation>Larsen MS, Fr&#xf8;lund S, N&#xf8;hr MK, Nielsen CU, Garmer M, Kreilgaard M, Holm R (2015) In vivo and in vitro evaluations of intestinal gabapentin absorption: effect of dose and inhibitors on carrier-mediated transport. Pharm Res 32(3):898&#x2013;909</Citation><ArticleIdList><ArticleId IdType="pubmed">25182974</ArticleId></ArticleIdList></Reference><Reference><Citation>Wakayama K (1987) Enhancement of the muscle relaxant action of baclofen by glucocorticoids. Nihon Yakurigaku Zasshi 89(2):81&#x2013;90</Citation><ArticleIdList><ArticleId IdType="pubmed">3570106</ArticleId></ArticleIdList></Reference><Reference><Citation>Mora JS, Genge A, Chio A et al (2019) Masitinib as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomized clinical trial. Amyotroph Lateral Scler Frontotemporal Degener 20:1&#x2013;10</Citation></Reference><Reference><Citation>Collo G, Cavalleri L, Bono F et al (2018) Ropinirole and pramipexole promote structural plasticity in human ipsc-derived dopaminergic neurons via BDNF and mTOR signaling. Neural Plast 2018:15</Citation></Reference><Reference><Citation>Lee J, Hyeon SJ, Im HJ, Ryu H, Kim Y, Ryu H (2016) Astrocytes and microglia as non-cell autonomous players in the pathogenesis of ALS. Exp Neurobiol 25(5):233&#x2013;240</Citation><ArticleIdList><ArticleId IdType="pubmed">27790057</ArticleId><ArticleId IdType="pmc">5081469</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>